5 months ago
IBRX
AnalystsAndres Y. MaldonadoAndres Y. Maldonado's Stock Forecasts
AnalystsAndres Y. Maldonado
Sectors:
Industries:
Analyst Ranking
Top 7%
#348 out of 5342 analysts
Average Return
+33.35%
Win Rate
60%41 out of 68
Risk vs Reward
Poor
Good
Andres Y. Maldonado's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Immunitybio IncIBRX | +243.64% | $2.36 | $8.11 | 2025-05-12 - 2026-05-11 | Buy |
Monopar TherapeuticsMNPR | +238.28% | $32.03 | $108.35 | 2025-08-26 - 2026-07-31 | Buy |
Immunitybio IncIBRX | +213.71% | $2.48 | $7.78 | 2025-04-16 - 2026-04-15 | Buy |
Terns Pharmaceuticals IncTERN | +203.27% | $17.43 | $52.86 | 2025-11-04 - 2026-03-25 | Buy |
Immunitybio IncIBRX | +199.67% | $2.99 | $8.96 | 2025-03-06 - 2026-03-05 | Buy |
Andres Y. Maldonado Analyst Color
Get additional color on Andres Y. Maldonado's coverage of popular stocks
Andres Y. Maldonado's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Monopar TherapeuticsMNPR | 4 | Buy | $125.00 | +15.37% | Maintains | 11 days ago |
Syndax Pharmaceuticals IncSNDX | 5 | Buy | $40.00 | +109.97% | Reiterates | 18 days ago |
Verastem IncVSTM | 3 | Buy | $18.00 | +210.34% | Reiterates | a month ago |
Relmada Therapeutics IncRLMD | 1 | Buy | $12.00 | +125.99% | Initiates Coverage On | a month ago |
Engene Therapeutics IncENGN | 5 | Buy | $4.00 | +123.46% | Maintains | 2 months ago |
Immunitybio IncIBRX | 11 | Buy | $15.00 | +109.21% | Reiterates | 2 months ago |
Corbus Pharmaceuticals Holdings IncCRBP | 3 | Buy | $40.00 | +345.93% | Reiterates | 2 months ago |
Cg Oncology IncCGON | 7 | Buy | $100.00 | +40.47% | Reiterates | 2 months ago |
Sutro Biopharma IncSTRO | 3 | Buy | $50.00 | +106.87% | Maintains | 3 months ago |
Immunome IncIMNM | 2 | Buy | $40.00 | +75.75% | Reiterates | 3 months ago |
Scholar Rock Holding CorpSRRK | 4 | Buy | $65.00 | +37.44% | Maintains | 3 months ago |
Novabridge BiosciencesNBP | 4 | Buy | $9.00 | +462.50% | Reiterates | 4 months ago |
Aura Biosciences IncAURA | 2 | Buy | $22.00 | +213.84% | Reiterates | 4 months ago |
Terns Pharmaceuticals IncTERN | 3 | Hold | $53.00 | +0.09% | Downgrades | 4 months ago |
Erasca IncERAS | 3 | Buy | $20.00 | +10.19% | Maintains | 5 months ago |
Foghorn Therapeutics IncFHTX | 1 | Buy | $13.00 | +186.98% | Reiterates | 5 months ago |
Day One Biopharmaceuticals IncDAWN | 3 | Hold | $21.50 | -0.14% | Downgrades | 5 months ago |
Protara Therapeutics IncTARA | 3 | Buy | $23.00 | +486.73% | Reiterates | 6 months ago |
Werewolf Therapeutics IncHOWL | 1 | Buy | $4.00 | +1,033.14% | Maintains | 7 months ago |
Tscan Therapeutics IncTCRX | 1 | Buy | $7.00 | +842.13% | Maintains | 9 months ago |
Merus NvMRUS | 1 | Hold | $97.00 | +7.78% | Downgrades | 10 months ago |
Candel Therapeutics IncCADL | 1 | Buy | $23.00 | +129.77% | Reiterates | 10 months ago |
Keros Therapeutics IncKROS | 1 | Buy | $20.00 | +98.61% | Maintains | a year ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.